Mycolic acids - Biological role and potential application in Mycobacterium detection and differentiation;Kwasy mikolowe - Rola biologiczna i potencjalne zastosowanie w wykrywaniu oraz róznicowaniu rodzaju Mycobacterium

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 68, Issue , 2014, Pages 350-358

  Kowalski, Konrad ^a   Trzepiński, Przemysław ^b   Druszczyńska, Magdalena ^b   Boratyński, Janusz ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

Author keywords

Biomarkers; Mycobacterium; Mycolic acids

Indexed keywords

FATTY ACID; MYCOLIC ACID;

BIOFILM; CELL WALL; CHEMISTRY; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; METABOLISM; MYCOBACTERIUM; PHYSIOLOGY; VIRULENCE;

BIOFILMS; CELL WALL; FATTY ACIDS; MYCOBACTERIUM; MYCOLIC ACIDS; VIRULENCE;

EID: 84920618572     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: 10.5604/17322693.1097425     Document Type: Review

References (69)

1. Alahari A., Alibaud L., Trivelli X., Gupta R., Lamichhane G., Reynolds R.C., Bishai W.R., Guerardel Y., Kremer L.: Mycolic acid methyltransferase, MmaA4, is necessary for thiacetazone susceptibility in Mycobacterium tuberculosis. Mol. Microbiol., 2009; 71: 1263-1277
2. Alibaud L., Alahari A., Trivelli X., Ojha A.K., Hatfull G.F., Guerardel Y., Kremer L.: Temperature-dependent regulation of mycolic acid cyclopropanation in saprophytic mycobacteria: role of the Mycobacterium smegmatis 1351 gene (MSMEG-1351) in CIS-cyclopropanation of α-mycolates. J. Biol. Chem., 2010; 285: 21698-21707
3. Anderson R.J.: Chemical investigation of biologically active lipoids of tubercle bacilli. Proc. Natl. Acad. Sci. USA, 1929; 15: 628-633
4. Asselineau J., Lederer E.: Structure of the mycolic acids of Mycobacteria. Nature, 1950; 166: 782-783
5. Barkan D., Hedhli D., Yan H.G., Huygen K., Glickman M.S.: Mycobacterium tuberculosis lacking all mycolic acid cyclopropanation is viable but highly attenuated and hyperinflammatory in mice. Infect. Immun., 2012; 80: 1958-1968
6. Barkan D., Liu Z., Sacchettini J.C., Glickman M.S.: Mycolic acid cyclopropanation is essential for viability, drug resistance, and cell wall integrity of Mycobacterium tuberculosis. Chem. Biol., 2009; 16: 499-509
7. Benadie Y., Deysel M., Siko D.G., Roberts V.V., Van Wyngaardt S., Thanyani S.T., Sekanka G., Ten Bokum A.M., Collett L.A., Grooten J., Baird M.S., Verschoor J.A.: Cholesteroid nature of free mycolic acids from M. tuberculosis. Chem. Phys. Lipids, 2008; 152: 95-103
8. Bendinger B., Rijnaarts H.H., Altendorf K., Zehnder A.J.: Physicochemical cell surface and adhesive properties of coryneform bacteria related to the presence and chain length of mycolic acids. Appl. Environ. Microbiol., 1993; 59: 3973-3977
9. Beukes M., Lemmer Y., Deysel M., Al Dulayymi J.R., Baird M.S., Koza G., Iglesias M.M., Rowles R.R., Theunissen C., Grooten J., Toschi G., Roberts V.V., Pilcher L., Van Wyngaardt S., Mathebula N., Balogun M., Stoltz A.C., Verschoor J.A.: Structure-function relationships of the antigenicity of mycolic acids in tuberculosis patients. Chem. Phys. Lipids, 2010; 163: 800-808
10. Brennan P.J., Crick D.C.: The cell-wall core of Mycobacterium tuberculosis in the context of drug discovery. Curr. Top. Med. Chem., 2007; 7: 475-488
11. Butler W.R., Guthertz L.S.: Mycolic acid analysis by high-performance liquid chromatography for identification of Mycobacterium species. Clin. Microbiol. Rev., 2001; 14: 704-726
12. Butler W.R., Kilburn J.O.: High-performance liquid-chromatography patterns of mycolic acids as criteria for identification of Mycobacterium chelonae, Mycobacterium fortuitum, and Mycobacterium smegmatis. J. Clin. Microbiol., 1990; 28: 2094-2098
13. Carter G., Wu M., Drummond D.C., Bermudez L.E.: Characterization of biofilm formation by clinical isolates of Mycobacterium avium. J. Med. Microbiol., 2003; 52: 747-752
14. Chan C.E., Zhao B.Z., Cazenave-Gassiot A., Pang S.W., Bendt A.K., Wenk M.R., MacAry P.A., Hanson B.J.: Novel phage display-derived mycolic acid-specific antibodies with potential for tuberculosis diagnosis. J. Lipid Res., 2013; 54: 2924-2932
15. Chen J.M., German G.J., Alexander D.C., Ren H., Tan T., Liu J.: Roles of Lsr2 in colony morphology and biofilm formation of Mycobacterium smegmatis. J. Bacteriol., 2006; 188: 633-641
16. Cole S.T., Barrell B.G.: Analysis of the genome of Mycobacterium tuberculosis H37Rv. Novartis Found. Symp., 1998; 217: 160-172
17. Dao D.N., Sweeney K., Hsu T., Gurcha S.S., Nascimento I.P., Roshevsky D., Besra G.S., Chan J., Porcelli S.A., Jacobs W.R.: Mycolic acid modification by the mmaA4 gene of M. tuberculosis modulates IL-12 production. PLoS Pathog., 2008; 4: e1000081
18. Donoghue H.D., Lee O.Y., Minnikin D.E., Besra G.S., Taylor J.H., Spigelman M.: Tuberculosis in Dr Granville's mummy: a molecular re-examination of the earliest known Egyptian mummy to be scientifically examined and given a medical diagnosis. Proc. Biol. Sci., 2010; 277: 51-56
19. Donoghue H.D., Spigelman M., Zias J., Gernaey-Child A.M., Minnikin D.E.: Mycobacterium tuberculosis complex DNA in calcified pleura from remains 1400 years old. Lett. Appl. Microbiol., 1998; 27: 265-269
20. Draper P.: The outer parts of the mycobacterial envelope as permeability barriers. Front. Biosci., 1998; 3: D1253-D1261
21. Dubnau E., Chan J., Raynaud C., Mohan V.P., Lanéelle M.A., Yu K., Quémard A., Smith I., Daffé M.: Oxygenated mycolic acids are necessary for virulence of Mycobacterium tuberculosis in mice. Mol. Microbiol., 2000; 36: 630-637
22. Fujita Y., Naka T., McNeil M.R., Yano I.: Intact molecular characterization of cord factor (trehalose 6, 6'-dimycolate) from nine species of mycobacteria by MALDI-TOF mass spectrometry. Microbiology, 2005; 151: 3403-3416
23. Fujita Y., Okamoto Y., Uenishi Y., Sunagawa M., Uchiyama T., Yano I.: Molecular and supra-molecular structure related differences in toxicity and granulomatogenic activity of mycobacterial cord factor in mice. Microb. Pathog., 2007; 43: 10-21
24. Gernaey A.M., Minnikin D.E., Copley M.S., Dixon R.A., Middleton J.C., Roberts C.A.: Mycolic acids and ancient DNA confirm an osteological diagnosis of tuberculosis. Tuberculosis, 2001; 81: 259-265
25. Glickman M.S., Cahill S.M., Jacobs W.R.Jr.: The Mycobacterium tuberculosis cmaA2 gene encodes a mycolic acid trans-cyclopropane synthetase. J. Biol. Chem., 2001; 276: 2228-2233
26. Hamasaki N., Isowa K., Kamada K., Terano Y., Matsumoto T., Arakawa T., Kobayashi K., Yano I.: In vivo administration of mycobacterial cord factor (trehalose 6, 6'-dimycolate) can induce lung and liver granulomas and thymic atrophy in rabbits. Infect. Immun., 2000; 68: 3704-3709
27. Hasegawa T., Leblanc R.M.: Aggregation properties of mycolic acid molecules in monolayer films: a comparative study of compounds from various acid-fast bacterial species. Biochim. Biophys. Acta, 2003; 1617: 89-95
28. Hershkovitz I., Donoghue H.D., Minnikin D.E., Besra G.S., Lee O.Y., Gernaey A.M., Galili E., Eshed V., Greenblatt C.L., Lemma E., Bar-Gal G.K., Spigelman M.: Detection and molecular characterization of 9, 000-year-old Mycobacterium tuberculosis from a neolithic settlement in the Eastern Mediterranean. PloS One, 2008; 3: e3426
29. Kolouchová I., Schreiberová O., Masák J., Sigler K., Rezanka T.: Structural analysis of mycolic acids from phenol-degrading strain of Rhodococcus erythropolis by liquid chromatography-tandem mass spectrometry. Folia Microbiol., 2012; 57: 473-483
30. Korf J.E., Pynaert G., Tournoy K., Boonefaes T., Van Oosterhout A., Ginneberge D., Haegeman A., Verschoor J.A., De Baetselier P., Grooten J.: Macrophage reprogramming by mycolic acid promotes a tolerogenic response in experimental asthma. Am. J. Respir. Crit. Care Med., 2006; 174: 152-160
31. Korf J., Stoltz A., Verschoor J., De Baetselier P., Grooten J.: The Mycobacterium tuberculosis cell wall component mycolic acid elicits pathogen-associated host innate immune responses. Eur. J. Immunol., 2005; 35: 890-900
32. Kowalski K., Szewczyk R., Druszczynska M.: Kwasy mikolowe - potencjalne markery diagnostyki oportunistycznych zakazeń mikroorganizmami z podrzędu Corynebacterineae. Postępy Hig. Med. Dos̈w., 2012; 66: 461-468
33. Lee O.Y., Wu H.H., Donoghue H.D., Spigelman M., Greenblatt C.L., Bull I.D., Rothschild B.M., Martin L.D., Minnikin D.E., Besra G.S.: Mycobacterium tuberculosis complex lipid virulence factors preserved in the 17, 000-year-old skeleton of an extinct bison, Bison antiquus. PloS One, 2012; 7: e41923
34. Lemmer Y., Thanyani S.T., Vrey P.J., Driver C.H., Venter L., van Wyngaardt S., ten Bokum A.M., Ozoemena K.I., Pilcher L.A., Fernig D.G., Stoltz A.C., Swai H.S., Verschoor J.A.: Detection of antimycolic acid antibodies by liposomal biosensors. Methods Enzymol., 2009; 464: 79-104
35. Liu J., Barry C.E.3rd, Besra G.S., Nikaido H.: Mycolic acid structure determines the fluidity of the mycobacterial cell wall. J. Biol. Chem., 1996; 271: 29545-29551
36. Mathebula N.S., Pillay J., Toschi G., Verschoor J.A., Ozoemena K.I.: Recognition of anti-mycolic acid antibody at self-assembled mycolic acid antigens on a gold electrode: a potential impedimetric immunosensing platform for active tuberculosis. Chem. Commun., 2009; 23: 3345-3347
37. Mederos L., Valdivia J.A., Valero-Guillen P.L.: Analysis of the structure of mycolic acids of Mycobacterium simiae reveals a particular composition of α-mycolates in strain 'habana' TMC 5135, considered as immunogenic in tuberculosis and leprosy. Microbiology, 2007; 153: 4159-4165
38. Mukherjee R., Chatterji D.: Proteomics and mass spectrometric studies reveal planktonic growth of Mycobacterium smegmatis in biofilm cultures in the absence of rpoZ. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2008; 861: 196-202
39. Ojha A., Anand M., Bhatt A., Kremer L., Jacobs W.R.Jr., Hatfull G.F.: GroEL1: a dedicated chaperone involved in mycolic acid biosynthesis during biofilm formation in mycobacteria. Cell, 2005; 123: 861-873
40. Ojha A.K., Baughn A.D., Sambandan D., Hsu T., Trivelli X., Guerardel Y., Alahari A., Kremer L., Jacobs W.R.Jr., Hatfull G.F.: Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria. Mol. Microbiol., 2008; 69: 164-174
41. Ojha A.K., Trivelli X., Guerardel Y., Kremer L., Hatfull G.F.: Enzymatic hydrolysis of trehalose dimycolate releases free mycolic acids during mycobacterial growth in biofilms. J. Biol. Chem., 2010; 285: 17380-17389
42. Ozoemena K.I., Mathebula N.S., Pillay J., Toschi G., Verschoor J.A.: Electron transfer dynamics across self-assembled N-(2-mercaptoethyl) octadecanamide/mycolic acid layers: impedimetric insights into the structural integrity and interaction with anti-mycolic acid antibodies. Phys. Chem. Chem. Phys., 2010; 12: 345-357
43. Pacheco S.A., Hsu F.F., Powers K.M., Purdy G.E.: MmpL11 protein transports mycolic acid-containing lipids to the mycobacterial cell wall and contributes to biofilm formation in Mycobacterium smegmatis. J. Biol. Chem., 2013; 288: 24213-24222
44. Pan J., Fujiwara N., Oka S., Maekura R., Ogura T., Yano I.: Anti-cord factor (trehalose 6, 6'-dimycolate) IgG antibody in tuberculosis patients recognizes mycolic acid subclasses. Microbiol. Immunol., 1999; 43: 863-869
45. Peyron P., Vaubourgeix J., Poquet Y., Levillain F., Botanch C., Bardou F., Daffé M., Emile J.F., Marchou B., Cardona P.J., de Chastellier C., Altare F.: Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog., 2008; 4: e1000204
46. Rachman H., Strong M., Ulrichs T., Grode L., Schuchhardt J., Mollenkopf H., Kosmiadi G.A., Eisenberg D., Kaufmann S.H.E.: Unique transcriptome signature of Mycobacterium tuberculosis in pulmonary tuberculosis. Infect. Immun., 2006; 74: 1233-1242
47. Recht J., Kolter R.: Glycopeptidolipid acetylation affects sliding motility and biofilm formation in Mycobacterium smegmatis. J. Bacteriol., 2001; 183: 5718-5724
48. Ren H., Dover L.G., Islam S.T., Alexander D.C., Chen J.M., Besra G.S., Liu J.: Identification of the lipooligosaccharide biosynthetic gene cluster from Mycobacterium marinum. Mol. Microbiol., 2007; 63: 1345-1359
49. Ryan G.J., Hoff D.R., Driver E.R., Voskuil M.I., Gonzalez-Juarrero M., Basaraba R.J., Crick D.C., Spencer J.S., Lenaerts A.J.: Multiple M. tuberculosis phenotypes in mouse and guinea pig lung tissue revealed by a dual-staining approach. PLoS One, 2010; 5: e11108
50. Sambandan D., Dao D.N., Weinrick B.C., Vilcheze C., Gurcha S.S., Ojha A., Kremer L., Besra G.S., Hatfull G.F., Jacobs W.R.: Keto-mycolic acid-dependent pellicle formation confers tolerance to drug-sensitive Mycobacterium tuberculosis. MBio., 2013; 4: e00222-00213
51. Sani M., Houben E.N., Geurtsen J., Pierson J., de Punder K., van Zon M., Wever B., Piersma S.R., Jiménez C.R., Daffé M., Appelmelk B.J., Bitter W., van der Wel N., Peters P.J.: Direct visualization by cryo-EM of the mycobacterial capsular layer: a labile structure containing ESX-1-secreted proteins. PLoS Pathog., 2010; 6: e1000794
52. Schleicher G.K., Feldman C., Vermaak Y., Verschoor J.A.: Prevalence of anti-mycolic acid antibodies in patients with pulmonary tuberculosis co-infected with HIV. Clin. Chem. Lab. Med., 2002; 40: 882-887
53. Shui G., Bendt A.K., Jappar I.A., Lim H.M., Laneelle M., Hervé M., Via L.E., Chua G.H., Bratschi M.W., Rahim S.Z., Michell, A.L., Hwang S.H., Lee J.S., Eum S.Y., Kwak H.K., Daffé M., Dartois V., Michel G., Barry C.E.3rd, Wenk M.R.: Mycolic acids as diagnostic markers for tuberculosis case detection in humans and drug efficacy in mice. EMBO Mol. Med., 2012; 4: 27-37
54. Song S.H., Park K.U., Lee J.H., Kim E.C., Kim J.Q., Song J.: Electrospray ionization-tandem mass spectrometry analysis of the mycolic acid profiles for the identification of common clinical isolates of mycobacterial species. J. Microbiol. Methods, 2009; 77: 165-177
55. Stratton H.M., Brooks P.R., Carr E.L., Seviour R.J.: Effects of culture conditions on the mycolic acid composition of isolates of Rhodococcus spp. from activated sludgefoams. Syst. Appl. Microbiol., 2003; 26: 165-171
56. Sugawara I., Udagawa T., Hua S.C., Reza-Gholizadeh M., Otomo K., Saito Y., Yamada H.: Pulmonary granulomas of guinea pigs induced by inhalation exposure of heat-treated BCG Pasteur, purified trehalose dimycolate and methyl ketomycolate. J. Med. Microbiol., 2002; 51: 131-137
57. Szewczyk R., Kowalski K., Janiszewska-Drobinska B., Druszczyńska M.: Rapid method for Mycobacterium tuberculosis identification using electrospray ionization tandem mass spectrometry analysis of mycolic acids. Diagn. Microbiol. Infect. Dis., 2013; 76: 298-305
58. Takayama K., Wang C., Besra G.S.: Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis. Clin. Microbiol. Rev., 2005; 18: 81-101
59. Thanyani S.T., Roberts V., Siko D.G., Vrey P., Verschoor J.A.: A novel application of affinity biosensor technology to detect antibodies to mycolic acid in tuberculosis patients. J. Immunol. Methods, 2008; 332: 61-72
60. Tran T.N., Aboudharam G., Raoult D., Drancourt M.: Beyond ancient microbial DNA: nonnucleotidic biomolecules for paleomicrobiology. Biotechniques, 2011; 50: 370-380
61. Tucker T.A., Crow S.A.Jr., Pierce G.E.: Effect of growth media on cell envelope composition and nitrile hydratase stability in Rhodococcus rhodochrous strain DAP 96253. J. Ind. Microbiol. Biotechnol., 2012; 39: 1577-1585
62. Uenishi Y., Fujita Y., Kusunose N., Yano I., Sunagawa M.: Comprehensive analysis of mycolic acid subclass and molecular species composition of Mycobacterium bovis BCG Tokyo 172 cell wall skeleton (SMP-105). J. Microbiol. Methods, 2008; 72: 149-156
63. Uenishi Y., Takii T., Yano I., Sunagawa M.: Separation and molecular characterization of mycolic acid from the cell wall skeleton of Mycobacterium bovis BCG Tokyo 172 (SMP-105) and BCG substrains by normal-phase high performance liquid chromatography and liquid chromatography/mass spectrometry. J. Microbiol. Methods, 2009; 77: 320-322
64. Viader-Salvado J.M., Garza-Gonzalez E., Valdez-Leal R., del Bosque-Moncayo M.A., Tijerina-Menchaca R., Guerrero-Olazaran M.: Mycolic acid index susceptibility method for Mycobacterium tuberculosis. J. Clin. Microbiol., 2001; 39: 2642-2645
65. Viader-Salvadó J.M., Molina-Torres C.A., Guerrero-Olazarán M.: Detection and identification of mycobacteria by mycolic acid analysis of sputum specimens and young cultures. J. Microbiol. Methods, 2007; 70: 479-483
66. Wick L.Y., Pasche N., Bernasconi S.M., Pelz O., Harms H.: Characterization of multiple-substrate utilization by anthracene-degrading Mycobacterium frederiksbergense LB501T. Appl. Environ. Microbiol., 2003; 69: 6133-6142
67. Wick L.Y., Wattiau P., Harms H.: Influence of the growth substrate on the mycolic acid profiles of mycobacteria. Environ. Microbiol., 2002; 4: 612-616
68. Yuan Y., Zhu Y., Crane D.D., Barry C.E.3rd: The effect of oxygenated mycolic acid composition on cell wall function and macrophage growth in Mycobacterium tuberculosis. Mol. Microbiol., 1998; 29: 1449-1458
69. Zambrano M.M., Kolter R.: Mycobacterial biofilms: a greasy way to hold it together. Cell, 2005; 123: 762-764